TAN-1120

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTAN-1120
Drug Alias NameIT-62-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsDiabetic RetinopathyArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic RetinopathyArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A